<--- Back to Details
First PageDocument Content
Immunodeficiency / Viral load / Antiretroviral drug / HIV / Long-term nonprogressor / Zidovudine / Acute HIV infection / Hepatitis C and HIV co-infection / HIV test / HIV/AIDS / Medicine / Millennium Development Goals
Date: 2014-09-22 02:17:33
Immunodeficiency
Viral load
Antiretroviral drug
HIV
Long-term nonprogressor
Zidovudine
Acute HIV infection
Hepatitis C and HIV co-infection
HIV test
HIV/AIDS
Medicine
Millennium Development Goals

IVRN Specimen Collections HIV The CD8 rescue collection: Stored peripheral blood mononuclear cells (PBMC) and plasma collected at multiple timepoints over a span of 5 years (1992 –1996) are available from HIV-infected

Add to Reading List

Source URL: ach2.publishpath.com

Download Document from Source Website

File Size: 109,20 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

DocID: 1m6of - View Document

Microsoft Word - Biographie de JF Delfraissy BIS.doc

Microsoft Word - Biographie de JF Delfraissy BIS.doc

DocID: 1gw3d - View Document

Surveillance and outbreak reports  Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

DocID: 1gvMD - View Document

Questioning the HIV-AIDS hypothesis: 30 years of dissent

Questioning the HIV-AIDS hypothesis: 30 years of dissent

DocID: 1gtoc - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

DocID: 1gtlL - View Document